Dec. 6, Thu.
The Nobel Prize: Shinya Yamanaka
The Genealogy of iPS Cells
Professor Shinya Yamanaka, Director of the Kyoto University Center for iPS Cell Research and Application (CiRA), was awarded this year's Nobel Prize in Physiology or Medicine.
Professor Yamanaka made the first iPS cell
Professor Shinya Yamanaka and Dr. John Gurdon during a press conference held at an international symposium in San Francisco.
Dr. John Gurdon of Cambridge University was also awarded this year's Nobel Prize in Physiology or Medicine.
Professor Shinya Yamanaka and Dr. Ian Wilmut meeting in Yokohama. Their conversation was broadcast on an earlier episode of Science View.
Dr. Ian Wilmut with the cloned sheep, Dolly.
Science watcher Katsuyuki Sakai speaking with Professor Shinya Yamanaka in the Science View studio.
Professor Shinya Yamanaka of Kyoto University was awarded this year's Nobel Prize in Physiology or Medicine for developing the first induced pluripotent stem cells (iPS cells). On this week's Science View we bring you a special Nobel Prize episode in advance of the award ceremony in Stockholm, Sweden, on December 10th.
On October 24th, a press conference was held with Shinya Yamanaka and John Gurdon of Cambridge University who shares this year's prize. At the time, the two scientists were attending an international symposium in San Francisco. The symposium was the first time the two had seen each other since announcement of their Nobel Prize. This week's special episode focuses on footage from the press conference, while giving an overview of iPS cells technology.
In 1962, Dr. Gurdon successfully reprogrammed the adult cells from an African clawed frog. Then, nearly half a century later in 2007, Professor Yamanaka made the first iPS cells. How are these two discoveries related?
iPS cell technology is nearly ready for clinical application. Shinya Yamanaka hopes to bring the benefits of iPS cell technology to patients with incurable diseases as soon as possible. John Gurdon and Shinya Yamanaka also share their views on the benefits and risks of clinical application.
On May 25th, 2012, we broadcast an edition of Science View in which Shinya Yamanaka joined us in the studio. During his visit, he spoke in detail about just how close iPS cell technology was to clinical application as well as the hurdles that still exist. Then, on July 13th and September 29th, we broadcast conversation held between Shinya Yamanaka and Ian Wilmut of Edinburgh University, the scientist who made the cloned sheep, Dolly. In this conversation, both scientists shared their views about the ethics of science. We will also rebroadcast portions of this discussion.
During a lecture in San Francisco Professor Yamanaka talked about two letters that hold special meaning to him. VW. But he's not referring to a car. To find out more, tune into Science View on Friday, December 7th.
Dropped video frames Found average frame timing of 33 ms Line Duration (ms) Time window No missing frames Total frames: 50399
This video has no dropped frames so has been marked as CFR by removing the timecodes. It will play on the PS3.
Get updates through the Hello Fun Time FaceBook page.
part 1 of 1: http://go4up.com/dl/1rmEcJFWsyfJ
No comments:
Post a Comment
I can't re-post files, sorry. The exception is files that are less than a day old. All mediafire links are broken forever. If you ask nicely and show that you tried but couldn't find the file elsewhere, someone may share it again.